Why the study?
Does reserpine monotherapy reduce blood pressure in participants with primary hypertension compared to placebo or no treatment?
Population
237 participants with primary hypertension across 4 RCTs
Comparison
Reserpine monotherapy vs Placebo or no treatment
Design
Meta-analysis
Authors
Loading...
Reserpine supports SBP reduction in primary hypertension; confirms efficacy but leaves optimal dosing and broader use open due to heterogeneity.
Does reserpine monotherapy reduce blood pressure in participants with primary hypertension compared to placebo or no treatment?
Reserpine monotherapy effectively reduces systolic blood pressure in patients with primary hypertension, though data on dose-response and other hemodynamic parameters are limited by trial heterogeneity and small sample sizes.
Shamon et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: